Revenue Breakdown
Composition ()
No data
Revenue Streams
ICU Medical Inc (ICUI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Infusion Consumables, accounting for 52.5% of total sales, equivalent to $278.27M. Other significant revenue streams include Consumables and Infusion Systems. Understanding this composition is critical for investors evaluating how ICUI navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, ICU Medical Inc maintains a gross margin of 38.89%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 5.73%, while the net margin is 5.68%. These profitability ratios, combined with a Return on Equity (ROE) of 2.26%, provide a clear picture of how effectively ICUI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ICUI competes directly with industry leaders such as ITGR and HAE. With a market capitalization of $3.12B, it holds a leading position in the sector. When comparing efficiency, ICUI's gross margin of 38.89% stands against ITGR's 25.16% and HAE's 56.47%. Such benchmarking helps identify whether ICU Medical Inc is trading at a premium or discount relative to its financial performance.
